These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11121706)

  • 21. Different effects of L-type and L+N-type calcium channel blockers on hamster cheek pouch venules.
    Kushiro T; Watanabe N; Takahashi A; Koike M; Saito F; Otsuka Y; Kanmatsuse K
    J Cardiovasc Pharmacol; 2004 Dec; 44(6):672-5. PubMed ID: 15550786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pranidipine enhances relaxation produced by endothelium-derived relaxing factor in carotid artery.
    Koshita M; Takano H; Nakahira Y; Suzuki H
    Eur J Pharmacol; 1999 Dec; 385(2-3):191-7. PubMed ID: 10607875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of specific T-type calcium channel blocker R(-) efonidipine in the regulation of renal medullary circulation.
    Hu C; Mori T; Lu Y; Guo Q; Sun Y; Yoneki Y; Ohsaki Y; Nakamichi T; Oba I; Sato E; Ogawa S; Dickinson BC; Chang CJ; Miyata T; Sato H; Ito S
    J Hypertens; 2012 Aug; 30(8):1620-31. PubMed ID: 22688264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antihypertrophic effect of dihydropyridines calcium channel blockers is dependent on their potential of blocking N-type calcium channel].
    Luo Q; Xuan WL; Xi F; Liao YL; Kitakaze M
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):755-9. PubMed ID: 20423843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.
    Cao X; Nakamura Y; Wada T; Izumi-Nakaseko H; Ando K; Zhu B; Xu B; Takahara A; Saitoh M; Sugiyama A
    Heart Vessels; 2016 Dec; 31(12):2045-2052. PubMed ID: 27194426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Takamatsu I; Ozawa Y; Saruta T
    J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies of the systemic hemodynamics and myocardial oxygen consumption of FRC 8653, a new Ca++ channel blocker, and nifedipine in anesthetized dogs.
    Chibana T; Noguchi K; Ojiri Y; Sakanashi M
    Jpn Heart J; 1992 Mar; 33(2):239-52. PubMed ID: 1593752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular profile of FPL 62129, a novel dihydropyridine calcium channel blocker, in anaesthetised dogs: a comparison with nifedipine.
    Humphries RG; O'Connor SE
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):332-8. PubMed ID: 2452927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of calcium channel blockers are not related to their chemical structure in the collar model of the rabbit.
    Yasa M; Kerry Z; Reel B; Yetik Anacak G; Ertuna E; Ozer A
    J Int Med Res; 2007; 35(1):59-71. PubMed ID: 17408056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemodynamic effects of a new dihydropyridine calcium entry blocker, S-12968-(-), in a rat model of cardiovascular calcium overload.
    Makki T; Lartaud I; Bray-des Boscs L; Capdeville-Atkinson C; Chillon JM; Hoffman M; Nicolas JP; Atkinson J
    Br J Pharmacol; 1992 May; 106(1):79-84. PubMed ID: 1324069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the renal action of pranidipine in the rat.
    Nagahama T; Hayashi K; Fujiwara K; Ozawa Y; Saruta T
    Arzneimittelforschung; 2000 Mar; 50(3):248-53. PubMed ID: 10758776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of pranidipine on N-type voltage-dependent Ca2+ channels in mice.
    Murakami M; Mori T; Nakagawasai O; Hagiwara K; Sakurada Y; Mobarakeh II; Murata A; Yamadera F; Miyoshi I; Tan-No K; Yanai K; Tadano T; Iijima T
    Neurosci Lett; 2004 Aug; 367(1):118-22. PubMed ID: 15308311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.
    Budriesi R; Aicardi G; Campana G; Spampinato S; Zaza A; Bisi A; Rampa A; Valenti P; Chiarini A
    Eur J Pharmacol; 1998 Oct; 359(2-3):161-70. PubMed ID: 9832387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbox ylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester (CV-159), on rat ischemic brain injury.
    Miyazaki H; Tanaka S; Fujii Y; Shimizu K; Nagashima K; Kamibayashi M; Uehara T; Okuma Y; Nomura Y
    Life Sci; 1999; 64(10):869-78. PubMed ID: 10096437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans.
    Strenn K; Matulla B; Wolzt M; Findl O; Bekes MC; Lamsfuss U; Graselli U; Rainer G; Menapace R; Eichler HG; Schmetterer L
    Clin Pharmacol Ther; 1998 Jan; 63(1):54-63. PubMed ID: 9465842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effects of a dual L/N-type Ca(2+) channel blocker cilnidipine in the rat focal brain ischemia model.
    Takahara A; Konda T; Enomoto A; Kondo N
    Biol Pharm Bull; 2004 Sep; 27(9):1388-91. PubMed ID: 15340224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of dihydropyridine sensitive calcium channels in glucose transport in skeletal muscle.
    Young JC; Balon TW
    Life Sci; 1997; 61(3):335-42. PubMed ID: 9217294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long-term treatment with calcium antagonists on periarterial nerve function in the mesenteric artery of spontaneously hypertensive rats.
    Nakatsuma A; Kawasaki H; Kurosaki Y; Futagami K; Araki H; Gomita Y
    Jpn J Pharmacol; 2000 Oct; 84(2):156-62. PubMed ID: 11128038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New dihydropyridine calcium channel antagonist, pranidipine, attenuates hypertensive renal injury in Dahl salt-sensitive rats.
    Uehara Y; Kawabata Y; Ohshima N; Hirawa N; Takada S; Numabe A; Nagata T; Goto A; Yagi S; Omata M
    J Cardiovasc Pharmacol; 1994 Jun; 23(6):970-9. PubMed ID: 7523790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
    Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
    Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.